Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients

Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer

(2016) Naoto Hadano et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Detection ofKRASMutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer

(2016) Nora Brychta et al.   CLINICAL CHEMISTRY

Opportunities and Challenges for Pancreatic Circulating Tumor Cells

(2016) Sunitha Nagrath et al.   GASTROENTEROLOGY

Antiangiogenic therapy in oncology: current status and future directions

(2016) Gordon C Jayson et al.   LANCET

Pancreatic cancer

(2016) Terumi Kamisawa et al.   LANCET

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

(2015) J. Tie et al.   ANNALS OF ONCOLOGY

Detection ofK-rasgene mutation by liquid biopsy in patients with pancreatic cancer

(2015) Hideaki Kinugasa et al.   CANCER

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

(2015) M. Ignatiadis et al.   CLINICAL CANCER RESEARCH

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery

(2015) Thomas Reinert et al.   GUT

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

(2015) Josep Tabernero et al.   LANCET ONCOLOGY

Whole genomes redefine the mutational landscape of pancreatic cancer

(2015) Nicola Waddell et al.   NATURE

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

(2015) Agnieszka K. Witkiewicz et al.   Nature Communications

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas

(2015) O. A. Zill et al.   Cancer Discovery

Molecular landscape of pancreatic cancer: implications for current clinical trials

(2015) Gregory M. Heestand et al.   Oncotarget

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

(2014) L. De Mattos-Arruda et al.   ANNALS OF ONCOLOGY

Liquid Biopsies: Genotyping Circulating Tumor DNA

(2014) Luis A. Diaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies

(2013) Lorenzo Fuccio et al.   GASTROINTESTINAL ENDOSCOPY

HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies

(2013) Diana P. English et al.   Molecular Diagnosis & Therapy

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

(2013) Sarah-Jane Dawson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

(2012) J Harder et al.   BRITISH JOURNAL OF CANCER

Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing

(2012) C. A. Iacobuzio-Donahue et al.   CLINICAL CANCER RESEARCH

Combinational therapy: New hope for pancreatic cancer?

(2011) Si Shi et al.   CANCER LETTERS

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

(2011) Hedy L Kindler et al.   LANCET ONCOLOGY

ATM Mutations in Patients with Hereditary Pancreatic Cancer

(2011) Nicholas J. Roberts et al.   Cancer Discovery

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

(2010) Hedy Lee Kindler et al.   JOURNAL OF CLINICAL ONCOLOGY

CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions

(2009) Daniele Marrelli et al.   AMERICAN JOURNAL OF SURGERY

Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer

(2009) Marc D. Tischkowitz et al.   GASTROENTEROLOGY

Adjuvant therapy for pancreatic cancer

(2007) Dan S. Zuckerman et al.   CANCER